Search

Search Constraints

You searched for: Author/Creator Ayton, Scott

Search Results

13. CSF ferritin in the clinicopathological progression of Alzheimer's disease and associations with APOE and inflammation biomarkers. Issue 3 (10th November 2022)

14. CuII(atsm) inhibits ferroptosis: Implications for treatment of neurodegenerative disease. (14th January 2020)

16. Deferiprone to delay dementia (the 3D trial): Human/Human trials: Other. (7th December 2020)

19. Erratum to: "Acute phase markers in CSF reveal inflammatory changes in Alzheimer's disease that intersect with pathology, APOE ε4, sex and age" [Prog. Neurobiol. 198 (2021) 101904]. (September 2021)